Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Ownership
Insiders


All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Inv. presentation
Quarterly results
Director comp.
Appointed director
CC transcript
ENZO BIOCHEM INC (ENZ) Create: Alert

All | News | Filings
Date FiledTypeDescription
07/28/2023 8-K/A Quarterly results
07/24/2023 8-K Quarterly results
07/24/2023 SC 13D/A Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
07/19/2023 EFFECT Form EFFECT - Notice of Effectiveness:
07/18/2023 424B3 Form 424B3 - Prospectus [Rule 424(b)(3)]:
07/18/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
07/17/2023 8-K Other Events  Interactive Data
07/10/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
07/10/2023 8-K Entry into a Material Definitive Agreement, Financial Statements and Exhibits  Interactive Data
Docs: "AMENDMENT NO. 1 TO ASSET PURCHASE AGREEMENT"
06/29/2023 11-K Form 11-K - Annual report of employee stock purchase, savings and similar plans:
06/16/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
06/16/2023 S-3 Form S-3 - Registration statement under Securities Act of 1933:
06/16/2023 8-K Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "UNAUDITED PRO FORMA CONDENSED CONSOLIDATED FINANCIAL INFORMATION OF THE COMPANY"
06/09/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
05/31/2023 4 Eckert Patricia (Interim CFO) has filed a Form 4 on ENZO BIOCHEM INC
Txns: Granted 25,000 options to buy @ $2.29, valued at $57.3k
05/26/2023 S-3/A Form S-3/A - Registration statement under Securities Act of 1933: [Amend]
05/10/2023 SC 13D/A Radoff Bradley Louis reports a 9.3% stake in Enzo Biochem, Inc.
05/08/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
05/08/2023 8-K Other Events  Interactive Data
04/24/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
04/24/2023 DEFM14A Form DEFM14A - Definitive proxy statement relating to merger or acquisition:
04/13/2023 8-K Quarterly results
04/05/2023 8-K Entry into a Material Definitive Agreement, Creation of a Direct Financial Obligation or an Obligation under an Off-Balance S...
Docs: "CREDIT AGREEMENT"
03/27/2023 SC 13D LABORATORY CORP OF AMERICA HOLDINGS reports a 9.8% stake in Enzo Biochem, Inc.
03/20/2023 10-Q Quarterly Report for the period ended January 31, 2023
03/16/2023 DEFA14A Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
03/16/2023 8-K Entry into a Material Definitive Agreement, Other Events, Financial Statements and Exhibits  Interactive Data
Docs: "ASSET PURCHASE AGREEMENT dated as of March 16, 2023 by and among LABORATORY CORPORATION OF AMERICA HOLDINGS, Enzo Clinical Labs, Inc.",
"Enzo Biochem Agrees to Sell Clinical Laboratory to Labcorp"
03/14/2023 NT 10-Q Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
02/13/2023 SC 13G/A Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
02/03/2023 8-K Quarterly results
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy